Nanoform Finland Oyj (NANOFH.HE)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Albert Alexander Haeggstrom | CFO & Director | 75k | -- | 1971 |
| Prof. Edward Olof Haeggstrom | Co-Founder & CEO | -- | -- | 1969 |
| Mr. Henri von Haartman | Director of Investor Relations | -- | -- | -- |
| Mr. Peter Hanninen | General Counsel & Chief Development Officer | -- | -- | 1988 |
| Dr. David Rowe | Head of Manufacturing | -- | -- | 1967 |
| Mr. Christian Jones | Chief Commercial Officer | -- | -- | 1980 |
| Mr. Antonio Da Silva | Chief of Business Operations | -- | -- | 1974 |
| Ms. Johanna Kause | Chief Quality Officer | -- | -- | 1971 |
| Dr. Jamie Unwin | Vice President of Strategic Insight | -- | -- | -- |
Nanoform Finland Oyj
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 181
Description
Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP, an online platform to pick winners among candidate molecules for CESS powered nanoforming. The company was founded in 2008 and is headquartered in Helsinki, Finland.
Corporate Governance
Upcoming Events
May 20, 2025 at 5:10 AM UTC
Nanoform Finland Oyj Earnings Date
Recent Events
Recent Events Information Not Available